U.S., May 21 -- ClinicalTrials.gov registry received information related to the study (NCT06980909) titled 'The Food Effect on Pharmacokinetics Study of QLC1101 in Healthy Subjects' on May 12.
Brief Summary: This randomized, open-label, three-period, three-treatment crossover Phase I clinical trial is designed to evaluate the pharmacokinetic profile of QLC1101 capsules administered as a single oral dose under fasting conditions, following a high-fat meal, and following a low-fat meal in healthy adult subjects. The study will further characterize the food effect on QLC1101 pharmacokinetics.
A total of 18 eligible subjects will be enrolled and randomized into three treatment sequences (A, B, C) using a balanced crossover design, with 6 subj...